|
Oct 3
|
Volition hosts NETs in sepsis management symposium at ESICM Lives 2024
|
|
Sep 30
|
Volition Appoints Dr. Ethel Rubin as an Independent Director
|
|
Aug 29
|
VNRX: Nu.Q Vet Test is now available in 17 countries. Cost cutting continues in a plan to be cash flow neutral in 2025. Management focused on signing licensing deals for Capture-PCR (human cancer detection method) and Nu.Q NET for sepsis. $7.0 million ...
|
|
Jun 25
|
VNRX: Cost cutting being implemented in a plan to be cash flow neutral in 2025. Distribution of Nu.Q Vet Test Expected to Expand During 2H 2024; Two Key R&D Efforts in 2024/25: 1) Breakthrough Cancer Detection Method (Capture-PCR) 2) Nu.Q NET for Sepsis
|
|
Jun 14
|
Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
|
May 15
|
VolitionRX Ltd (VNRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances and ...
|
|
May 13
|
VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update
|
|
May 8
|
VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update
|
|
Apr 23
|
Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech
|
|
Apr 8
|
VNRX: VolitionRx Reports 2023 Results; Distribution of Nu.Q Vet Test Expanding; Nu.Q Discover Growing; Two Key R&D Efforts in 2024/25: 1) Breakthrough Cancer Detection Method (Capture -PCR) 2) Nu.Q NET for Sepsis
|
|
Mar 27
|
VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript
|
|
Mar 25
|
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
|
|
Mar 21
|
VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
|
|
Mar 20
|
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
|
|
Mar 19
|
Volition appoints Dr Andrew Retter as Chief Medical Officer
|
|
Dec 5
|
Sidoti Events, LLC's Virtual December Small-Cap Conference
|
|
Dec 5
|
VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre
|
|
Nov 16
|
VolitionRx Limited (AMEX:VNRX) Q3 2023 Earnings Call Transcript
|
|
Nov 14
|
VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update
|
|
Aug 9
|
VolitionRx Limited Schedules Second Quarter 2023 Earnings Conference Call and Business Update
|